Nancy Mueller
Professor

Nancy Mueller

Professor of Epidemiology, Emerita

Epidemiology

nmueller@hsph.harvard.edu


Overview

Research

There is evidence that under certain conditions, viral and other infections play an integral role in carcinogenesis. These infections establish latency or are chronic; age and severity of infection are generally risk factors for malignancy. Understanding the natural history of such infections and identification of the risk factors for malignancy may provide insight for intervention strategies.

Dr. Mueller's major research has been on the role of age at infection with the Epstein -Barr virus (EBV) on the pathogenesis of Hodgkin's lymphoma (HL). Her group conducted research on the natural history of the first identified human retrovirus, HTLV- I, and hepatitis C virus in longitudial studies of endemic villages in southern Japan.

BA (cum laude), 1961, Biology
Beloit College

SM, 1974, Epidemiology
Harvard School of Public Health

SD, 1980, Epidemiology
Harvard School of Public Health


Bibliography

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Benavides AG, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Isaacs MB, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A.

N Engl J Med. 2021 Sep 29. PMID: 34587382